Drug · DIN 02232043
ARICEPT
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 20, 1997; first marketed August 20, 1997.
- Drug Identification Number (DIN)
- 02232043
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Donepezil N06DA02
- Class
- Human
- Record last updated
- June 25, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DONEPEZIL HYDROCHLORIDE | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 12, 1997: NOC 3745New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “aricept”. A notice may cover another product or only some lots: read it to see what it covers.
- Alzheimer's drug Aricept (donepezil) - New warnings on the serious risks of muscle breakdown and of a neurological disorderJanuary 21, 2015 · Drugs · Labelling - New safety information - Product safety
Other DINs named ARICEPT
- DIN 02232044 · Marketed